Проблема избыточного веса в мире (обзор литературы)
About the Authors
К. РахметоваKazakhstan
А. Маншарипова
Kazakhstan
С. Бекетова
Kazakhstan
References
1. Ивлева А.Я., Старостина Е.Г. Ожирение – проблема медицинская. – М.: 2002. – 176 с.
2. American Obesity Association. AOA fact Sheets: Obesity in the USA // www. Obesity.org. 2007.
3. De Koning L., Merchant A.T., Pogue J., Anand S.S. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies // Eur. Heart J., 2007; 2: P. 850–856.
4. Lavie C.J., Milani R.V., Artham S.M. et al. The obesity paradox, weight loss, and coronary disease // Am. J. Med., 2009;12: P. 1106–1114.
5. Бессен Д.Г., Кушнер Р. Избыточный вес и ожирение. Профилактика, диагностика и лечение. – М.: ЗАО «Изд. БИНОМ», 2004. – 240 с.
6. Bray G.A., Blakburn G.L., Ferguson J.M. et al. Sibutramine produces dose-related weight loss // Obesity Res., 1999; 7: P. 189–198.
7. Hubert H.B., Feinleib M., McNamara P.H. Obesity as an independent risk factor for cardiovascular disease: a 26-yeae follow-up of participants in the Framingham Heart Study // Circulation, 1993;
8. Hellmich N. Obesity linked to specific cancers // USA TODAY, 2009. – 11. – 05. 10: P.
9. Moklad A.H., Bowman B.A., Ford E.S. et al. The continuing epidemics of obesity and diabetes in the United States // JAMA, 2001; 11: P. 1195–1200.
10. Obesity impact on GER symptoms examined // www. Medwirenews. md. 2009.
11. Sjostrom L., Rissanen A., Andersen T. et al. Randomized placebocontrolled trial of orlistat for weight loss and prevention of weight regain in obese patients // Lancet,2008; 5: P. 167–172.
Review
For citations:
, , . Actual Problems of Theoretical and Clinical Medicine. 2019;(4):49-50. (In Russ.)